John M. Berge

1.2k total citations
29 papers, 977 citations indexed

About

John M. Berge is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, John M. Berge has authored 29 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in John M. Berge's work include RNA and protein synthesis mechanisms (11 papers), Microbial Natural Products and Biosynthesis (5 papers) and Receptor Mechanisms and Signaling (5 papers). John M. Berge is often cited by papers focused on RNA and protein synthesis mechanisms (11 papers), Microbial Natural Products and Biosynthesis (5 papers) and Receptor Mechanisms and Signaling (5 papers). John M. Berge collaborates with scholars based in United Kingdom, United States and Italy. John M. Berge's co-authors include Richard L. Jarvest, Helen Chapman, Dougal J. Ritson, Russell J. Cox, Paul Young, Michael A. Cawthorne, Stanley M. Roberts, Peter J. O’Hanlon, Pamela Brown and C. S. V. HOUGE‐FRYDRYCH and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John M. Berge

26 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Berge United Kingdom	18	543	418	97	90	88	29	977
David F. Corbett United Kingdom	19	662 1.2×	286 0.7×	154 1.6×	217 2.4×	105 1.2×	47	1.4k
Theresa M. Kelly United States	16	564 1.0×	179 0.4×	66 0.7×	66 0.7×	51 0.6×	23	1.1k
Peter A. Smith United States	18	610 1.1×	128 0.3×	212 2.2×	163 1.8×	79 0.9×	31	1.0k
André Schanck Belgium	19	713 1.3×	101 0.2×	40 0.4×	98 1.1×	35 0.4×	47	1.3k
Salvatore Pacifico Italy	18	630 1.2×	439 1.1×	123 1.3×	56 0.6×	34 0.4×	64	1.4k
Michele R. Richards Canada	22	1.1k 2.1×	623 1.5×	395 4.1×	55 0.6×	65 0.7×	36	1.7k
R. A. DAINES United States	14	363 0.7×	598 1.4×	52 0.5×	247 2.7×	72 0.8×	25	961
Roya Zoraghi United States	20	849 1.6×	298 0.7×	44 0.5×	339 3.8×	63 0.7×	31	1.2k
Erika Fornasari Italy	18	379 0.7×	152 0.4×	62 0.6×	135 1.5×	49 0.6×	28	876
Yasuchika Yamaguchi Japan	16	346 0.6×	216 0.5×	181 1.9×	39 0.4×	29 0.3×	26	762

Countries citing papers authored by John M. Berge

Since Specialization

Citations

This map shows the geographic impact of John M. Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Berge more than expected).

Fields of papers citing papers by John M. Berge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Berge. The network helps show where John M. Berge may publish in the future.

Co-authorship network of co-authors of John M. Berge

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Berge. A scholar is included among the top collaborators of John M. Berge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Berge. John M. Berge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paljetak, Hana Čipčić, et al.. (2011). Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity. Bioorganic & Medicinal Chemistry. 19(23). 7281–7298. 25 indexed citations

Paljetak, Hana Čipčić, Gorjana Lazarevski, Sulejman Alihodžić, et al.. (2010). 4″-O-(ω-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens. Bioorganic & Medicinal Chemistry. 18(17). 6559–6568. 26 indexed citations

Cox, Russell J., et al.. (2005). Room temperature palladium catalysed coupling of acyl chlorides with terminal alkynes. Chemical Communications. 1037–1037. 116 indexed citations

Ritson, Dougal J., Russell J. Cox, & John M. Berge. (2004). Indium mediated allylation of glyoxylate oxime ethers, esters and cyanoformates. Organic & Biomolecular Chemistry. 2(13). 1921–1921. 35 indexed citations

Jarvest, Richard L., John M. Berge, Pamela Brown, et al.. (2004). Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues. Bioorganic & Medicinal Chemistry Letters. 14(15). 3937–3941. 44 indexed citations

Jarvest, Richard L., John M. Berge, Pamela Brown, et al.. (2003). Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-Positive antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 13(7). 1265–1268. 22 indexed citations

Jarvest, Richard L., John M. Berge, Murray J. B. Brown, et al.. (2003). Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 13(4). 665–668. 32 indexed citations

Qiu, Xiayang, Cheryl A. Janson, Ward W. Smith, et al.. (2001). Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors. Protein Science. 10(10). 2008–2016. 166 indexed citations

Jarvest, Richard L., John M. Berge, C. S. V. HOUGE‐FRYDRYCH, et al.. (2001). Inhibitors of Bacterial Tyrosyl tRNA Synthetase: Synthesis of Carbocyclic Analogues of the Natural Product SB-219383. Bioorganic & Medicinal Chemistry Letters. 11(18). 2499–2502. 10 indexed citations

10.

Jarvest, Richard L., John M. Berge, Pamela Brown, et al.. (2001). Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383. Bioorganic & Medicinal Chemistry Letters. 11(5). 715–718. 18 indexed citations

11.

Berge, John M., C. S. V. HOUGE‐FRYDRYCH, & Richard L. Jarvest. (2001). Lewis-acid catalysed arylation of the hydroxyamino sugar moiety of the natural product SB-219383. Journal of the Chemical Society Perkin Transactions 1. 2521–2523. 4 indexed citations

12.

Berge, John M., Royston C. B. Copley, Drake S. Eggleston, et al.. (2000). Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of four stereoisomeric analogues of the natural product SB-219383. Bioorganic & Medicinal Chemistry Letters. 10(16). 1811–1814. 28 indexed citations

13.

Berge, John M., N. J. P. BROOM, C. S. V. HOUGE‐FRYDRYCH, et al.. (2000). Synthesis and Activity of Analogues of SB-219383. Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase.. The Journal of Antibiotics. 53(11). 1282–1292. 20 indexed citations

14.

Jarvest, Richard L., John M. Berge, C. S. V. HOUGE‐FRYDRYCH, et al.. (1999). Interaction of tyrosyl aryl dipeptides with S. aureus tyrosyl tRNA synthetase: Inhibition and crystal structure of a complex. Bioorganic & Medicinal Chemistry Letters. 9(19). 2859–2862. 10 indexed citations

15.

Sennitt, Matthew V., Alberto J. Kaumann, Peter Molenaar, et al.. (1998). The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.. PubMed. 285(3). 1084–95. 53 indexed citations

16.

Sennitt, Matthew V., Alberto J. Kaumann, Peter Molenaar, et al.. (1998). The Contribution of Classical (β1/2-) and Atypical β-Adrenoceptors to the Stimulation of Human White Adipocyte Lipolysis and Right Atrial Appendage Contraction by Novel β3-Adrenoceptor Agonists of Differing Selectivities. Journal of Pharmacology and Experimental Therapeutics. 285(3). 1084–1095. 23 indexed citations

17.

Beeley, Lee J., John M. Berge, Helen Chapman, et al.. (1995). Synthesis of a selective alpha-2A adrenoceptor antagonist, BRL 48962, and its characterization at cloned human alpha-adrenoceptors. Bioorganic & Medicinal Chemistry. 3(12). 1693–1698. 8 indexed citations

18.

Berge, John M., et al.. (1994). An Alternative Route to Aryloxymethylphosphonates and Phosphinates via Fluoride Ion Displacement from Activated Aromatic Substrates. Synlett. 1994(3). 187–188. 3 indexed citations

19.

Young, Paul, John M. Berge, Helen Chapman, & Michael A. Cawthorne. (1989). Novel α2-adrenoceptor antagonists show selectivity for α2A- and α2B-adrenoceptor subtypes. European Journal of Pharmacology. 168(3). 381–386. 101 indexed citations

20.

Berge, John M., et al.. (1980). Epoxy ring-opening reactions of endo- and exo-3,4-epoxy-6-azabicyclo[3.2.0] heptan-7-ones. Journal of the Chemical Society Perkin Transactions 1. 690–690. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact